Mutations in cardiac sarcomere protein genes are associated with a variety of clinical phenotypes, including hypertrophic (HCM), dilated (DCM), and restrictive (RCM) cardiomyopathy as well as left ventricular non-compaction, with the overlap of morpho-functional manifestations in individual patients and families. Over time, initial phenotypes may undergo profound changes which determine clinical course and disease progression. Although genetic defects causingHCMandDCMhave opposite effects at the myofilament level, a number of downstream maladaptive mechanisms, ranging frommicrovascular dysfunction and ischaemia to myocardial fibrosis and fromdiastolic dysfunction to abnormal sympathetic activation and arrhythmogenesis, seem to recur in sarcomeric cardiomyopathies, independent of the presenting phenotype. The extent and rate at which each of these features occur and evolve may be radically different in each form of cardiomyopathy, determining a clinical heterogeneity that is not only cross-sectional, but also longitudinal, i.e. time-related. Timely and sensitive detection of these long-term modifications in the clinical setting is a key to preventing advanced disease and identifying novel therapeutic targets. The present review evaluates the contribution of contemporary technology to pre-clinical diagnosis, characterization of phenotypes, and assessment of disease progression in sarcomere cardiomyopathies, including echocardiography, positron emission tomography, magnetic resonance, pathology, and circulating biomarkers.

Defining phenotypes and disease progression in sarcomeric cardiomyopathies: Contemporary role of clinical investigations / Olivotto I.; D'Amati G.; Basso C.; Van Rossum A.; Patten M.; Emdin M.; Pinto Y.; Tomberli B.; Camici P.G.; Michels M.. - In: CARDIOVASCULAR RESEARCH. - ISSN 0008-6363. - STAMPA. - 105:(2015), pp. 409-423. [10.1093/cvr/cvv024]

Defining phenotypes and disease progression in sarcomeric cardiomyopathies: Contemporary role of clinical investigations

Olivotto I.;Tomberli B.;
2015

Abstract

Mutations in cardiac sarcomere protein genes are associated with a variety of clinical phenotypes, including hypertrophic (HCM), dilated (DCM), and restrictive (RCM) cardiomyopathy as well as left ventricular non-compaction, with the overlap of morpho-functional manifestations in individual patients and families. Over time, initial phenotypes may undergo profound changes which determine clinical course and disease progression. Although genetic defects causingHCMandDCMhave opposite effects at the myofilament level, a number of downstream maladaptive mechanisms, ranging frommicrovascular dysfunction and ischaemia to myocardial fibrosis and fromdiastolic dysfunction to abnormal sympathetic activation and arrhythmogenesis, seem to recur in sarcomeric cardiomyopathies, independent of the presenting phenotype. The extent and rate at which each of these features occur and evolve may be radically different in each form of cardiomyopathy, determining a clinical heterogeneity that is not only cross-sectional, but also longitudinal, i.e. time-related. Timely and sensitive detection of these long-term modifications in the clinical setting is a key to preventing advanced disease and identifying novel therapeutic targets. The present review evaluates the contribution of contemporary technology to pre-clinical diagnosis, characterization of phenotypes, and assessment of disease progression in sarcomere cardiomyopathies, including echocardiography, positron emission tomography, magnetic resonance, pathology, and circulating biomarkers.
2015
105
409
423
Olivotto I.; D'Amati G.; Basso C.; Van Rossum A.; Patten M.; Emdin M.; Pinto Y.; Tomberli B.; Camici P.G.; Michels M.
File in questo prodotto:
File Dimensione Formato  
cvres olivotto clinical investigation 2015.full.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: DRM non definito
Dimensione 884.07 kB
Formato Adobe PDF
884.07 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1180488
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 56
  • ???jsp.display-item.citation.isi??? 55
social impact